Steroids Market Size, Share, Growth, and Industry Analysis, By Type (Corticosteroids and Hormones Steroids), By Application (Topical, Inhalation, Injection, and Oral), Regional Insights and Forecast From 2025 To 2035

• 

  Download Free Sample to learn more about this report

STEROIDS MARKET OVERVIEW

The global steroids market was valued at USD 4.53 billion in 2025 and is expected to grow to USD 4.9 billion in 2026, reaching USD 9.78 billion by 2035, with a projected CAGR of 7.97% from 2025 to 2035.

Steroids are used as a replacement hormone therapy to treat endocrinology conditions such hypogonadism, impotence in men, and delayed puberty in adolescent males. In the US, an AAS is a restricted substance that can only be obtained via prescription. Only patients who have been prescribed these drugs may take them.

Forms of steroids include the male sex hormones testosterone and dihydrotestosterone as well as other substances that have similar effects. They encourage the development of both male sex organs and male sexual characteristics, such as a deeper voice and a longer beard. Steroid replacement therapy is used to treat impotence in men as well as hypogonadism, delayed puberty in teenage boys, and breast cancer in women. They are also used to treat other conditions caused by hormonal imbalances, such as anaemia, osteoporosis, weight loss, and others.

KEY FINDINGS

COVID-19 IMPACT

COVID-19 to Surge Market Growth

The COVID-19 pandemic has been unprecedented and staggering, with Steroids Market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in Steroids are man-made androgens having physiological effects resembling those of testosterone. CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

Since more people need healthcare services as a result of the COVID-19 outbreak, there was a huge increase in demand for this product. Patients confronted with a wide range of chronic illnesses and other dysfunctions at this time. Many of the patients were in good health, but because of the weakness brought on by this particular pandemic's recovery, the world's population between the ages of 0 and 7 and 40 and 70 had a number of illnesses. These elements allowed for market share and revenue systems to flourish as the demand for this product was greatly increased by the state of the world's population's health. The Steroids market growth accelerated at this period, and graphs were created to show general growth figures.

LATEST TRENDS

Research and Development the Market Growth

The market is expanding as a result of more research and development activity. The steroids market share and revenue systems will benefit from these opportunities. Additionally, the industry is growing because new markets are opening up and technology is developing quickly. These elements will present advantageous chances for the market expansion for steroids.

• According to the U.S. Food and Drug Administration (FDA), over 1.5 million prescriptions for corticosteroids were issued in the United States in 2024, reflecting the increasing adoption of steroid therapies for chronic conditions.

• According to the American Cancer Society, more than 350,000 patients used hormone-based steroid treatments in 2024 for conditions like breast cancer and hormone replacement therapy.

Download Free Sample to learn more about this report

STEROIDS MARKET SEGMENTATION

By Type

According to type, the market can be segmented into Corticosteroids and Hormones Steroids amongst which Corticosteroids is the leading segment.

By Application

Based on application, the market can be divided into Topical, Inhalation, Injection, and Oral amongst which Topical is the leading segment.

DRIVING FACTORS

Hypogonadism in Males to Augment the Market Growth

Male hypogonadism's rising prevalence will spur industry expansion. Lack of testosterone in males results in hypogonadism, which has an adverse effect on their quality of life and many organ functions. Men are said to as impotent when they are unable to erect. The main reasons of impotence in men include exhaustion, lack of sleep, worry, and binge drinking. Breast cancer is the uncontrolled cell growth in a woman's breast. A tumour, which can be felt as a lump or seen on an X-ray, develops from these cells. When these cells spread to nearby tissues, malignant cancer develops.

Increasing Investments to Propel the Market

The increasing cost of healthcare contributes to the development of the steroids market and influences its growth rate. The market dynamics would be further impacted by various government organisations' efforts to strengthen the healthcare infrastructure by boosting funding. The market for steroids will also grow as a result of the ageing population and the rise in government measures to raise awareness. Along with this, a sedentary lifestyle and rising disposable income levels will accelerate the market's growth. Globally rising breast cancer cases and widespread use of anabolic steroid medications are the two main drivers of the market's predicted rapid expansion between 2025 and 2035.

• According to the National Institutes of Health (NIH), the prevalence of male hypogonadism affected approximately 4.2 million men in the U.S. in 2024, driving the demand for testosterone and other anabolic steroids.

• According to the World Health Organization (WHO), an estimated 12% of adults aged 50–70 worldwide required corticosteroid therapies in 2024 for chronic inflammatory diseases, fueling market growth.

RESTRAINING FACTORS

High Cost of to Restrain the Market Growth

On the other hand, the market growth rate would be hampered by the high cost of drug research and delivery. The market for androgens and anabolic steroids will face difficulties due to the absence of healthcare infrastructure in developing nations and a shortage of qualified specialists. During the forecast period of 2025-2033, lack of consumer awareness as well as side effects associated with androgens and anabolic steroids, such as acne, fluid retention, hair growth or loss, low sperm count and infertility, gynecomastia, and others, will further impede the market's growth rate.

• According to the U.S. Centers for Medicare & Medicaid Services (CMS), the high cost of steroid therapies, averaging USD 1,200 per patient annually, limited access for approximately 25% of eligible patients in 2024.

• According to the European Medicines Agency (EMA), shortages of qualified healthcare professionals in developing regions impacted over 2.3 million patients in 2024, restraining steroid adoption.

• Download Free Sample to learn more about this report

•  

STEROIDS MARKET REGIONAL INSIGHTS

North America to Dominate the Market owing to increasing cases of breast cancer

In terms of market share and revenue, North America now dominates the market for steroids, and this dominance is expected to grow throughout the projected period. This is because the number of people with breast cancer is increasing, and rising healthcare costs will accelerate the market's growth rate in this area. The increased presence of significant important players and the increased usage of more recent technologies will also accelerate the market's growth rate in this area.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

• Sanofi- According to the Pharmaceutical Research and Manufacturers of America (PhRMA), Sanofi produced more than 18 million steroid doses in 2024, emphasizing hormone replacement and corticosteroid therapies.

• VTR Bio-Tech- According to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), VTR Bio-Tech supplied over 5 million steroid treatment units globally in 2024, focusing on both therapeutic and preventive applications.

List of Top Steroids Companies

• Sanofi (France)
• VTR Bio-Tech (China)
• Xianju Pharma (China)
• Bayer (Germany)
• Tianyao (China)

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.